Test Discontinuation Memorandum

Effective December 9, 2015, Baylor Miraca Genetics Laboratories (BMGL) will make the following modifications to its test menu:

  • Test code 9126 (KRAS Mutation Analysis codons 12, 13, 61) will be replaced by test code 9128 (KRAS Mutation Analysis Codons 12, 13).
  • Discontinuation of test code 9050 – MPD Panel (includes Identification of JAK2 V617F, JAK2 exon 12 and MPL Exon 10 mutations).
    • Tests for myeloproliferative neoplasms are available individually:
      • JAK2 V617F Mutation Analysis (test code 9010)
      • JAK2 Exon 12 Mutation Analysis (test code 9015)
      • MPL Exon 10 Mutation Analysis (test code 9020)
      • CALR Exon 9 Mutation Analysis (test code 9016)
Previous Post
Baylor Genetics Incorporates Oxford Gene Technology’s SNP Array Probe Technology
Next Post
Test Discontinuation Memorandum